Document is current
Any future updates will be listed below
-
Authors
García Sebastián, Cristina
Climent Payá, Vicente
Castillo, Juan Carlos
Urbano-Moral, José Ángel
Ruz Zafra, Aurora
Valle Caballero, María José
Zamorano, José Luis
Lobán, Covadonga Fernández-Golfín
Pereda, David Cordero
Álvarez, María Isabel García
Ajo, María
Paredes Hurtado, Nick Iván
Dorado, Ernesto Martín
Ángel Urbano, José
Tamargo, Luis
Guerrero, Franiosco José
Trujillo, Francisco
Chaparro, María Marinela
García Pinilla, José Manuel
Flores, Jesús Piqueras
Belchi, Joaquina
Mogollón, María Victoria
Martínez, Marina
García, Ana
Prat, Susana
Mateo, Irene
Idiazábal, Uxue
Mastracchio, Victoria Piro
Peña, María Luisa
Velasco, Sonia
Rodríguez, Ibón
Limeres, Javier
Rodríguez Palomares, José
Manovel, Ana
López Ayala, José María
Roy, Laura Álvarez
Medina Gil, José María
Marrero, Natalia
Alania, Edgardo
Monzonis, Amparo Martínez
Escudero, Aída
Boing, Irene
-
Funding
Funding for this research was provided by:
Sociedad Española de Cardiología
Takeda Pharmaceuticals International (IISR-2018-104269)
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Prevalence of Fabry disease in patients with left ventricular hypertrophy and renal involvement (PrEFaCe)
Journal Title: Medicina Clínica (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2024.06.006
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2024.06.009
Content Type: article
Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
